Market Trends of Non-invasive Aesthetic Treatment
Injectable Segment is Expected to Occupy a Significant Market Share Over the Forecast Period
In terms of procedure, the injectable segment is expected to occupy a significant market share in the forecast period as compared to other procedures like skin rejuvenation, non-surgical fat removal, etc. Compared to other available options in the injectable segment, the botulinum toxin (most commonly known as Botox) market is increasing very rapidly and is the most widely used injectable in non-invasive beauty enhancement procedures, worldwide. As per a 2019 report by the International Society of Aesthetic Plastic Surgery, 6,271,488 botulinum toxin procedures were done globally, constituting 46.1% of the total non-invasive procedures.
The other factors complementing the growth of the injectables market are new R&D in the area and the launch of a new and advanced solution by the key market players in the area who are actively working toward bringing improvement in the non-invasive aesthetic treatment market. For example, in June 2021, the United States Food and Drug Administration provided its approval to Galderma's Restylane Contour for improving cheek augmentation and midface contour deficiencies. In January 2020, the Allergan facility in the Mayo town of Westport shipped the 100 millionth vial of Botox. The Westport facility is responsible for manufacturing the global supply of the anti-wrinkle injection treatment, as the company marked 30 years since the product first received approval.
North America is Expected to Dominate the Non-Invasive Aesthetic Treatment Market during the Forecast Period
North America is expected to dominate the market of non-invasive aesthetic treatment during the forecast period mainly due to the increasing demand for beauty-enhancing procedures and the availability of a handful of resources in the region. Among all, the United States is expected to be the largest market in the North American region for the market studied. According to the 2020 report of the American Society of Plastic Surgeons, Americans have a more positive opinion toward plastic surgery or non-surgical procedures than before the COVID-19 pandemic. It also reported that about 11% of the surveyed women were interested in getting either surgical or non-surgical cosmetics procedures. The number was higher in the women who already had surgery or any kind of cosmetic procedure, about 24%.
As per the 2020 report of the International Society of Aesthetic Plastic Surgery, in 2019 the United States and Mexico were two of the top 10 countries where most cosmetic surgeries and procedures (both surgical and non-surgical) were performed. As per the International Society of Aesthetic Plastic Surgery (ISAPS) Report, 2019, the total number of botulinum A procedures that were performed accounted for 287,420 constituting 46.4% of non-surgical procedures in Mexico.
The major reason was the increasing popularity of the aesthetic treatment in the region for beauty enhancement in both adults and old age populations. Additionally, the presence of few key market leaders in the region augments the growth of the market, as they promote their products via different sources and provide better services in the region. For example, in October 2020, BTL Aesthetics announced the launch of the EMSCULPT NEO for the non-invasive procedure in the removal of fat cells and treating body contouring.
Thus, the above factors are likely to contribute to the growth of the non-invasive aesthetic treatment market in the region, along with its dominance in the market.
